.png){kind=icon}
.png){kind=icon}
Return
Accelerating Drug Development Using Spatial Multi-omics
.png){kind=icon}
OA
AI
DOI：10.1158/2159-8290.CD-24-0101.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Spatial biology approaches enabled by innovations in imaging biomarker platforms and artificial intelligence-enabled data integration and analysis provide an assessment of patient and disease heterogeneity at ever-increasing resolution. The utility of spatial biology data in accelerating drug programs, however, requires balancing exploratory discovery investigations against scalable and clinically applicable spatial biomarker analysis.
Keywords:
ARTIFICIAL-INTELLIGENCE